FDA Approves Bosutinib for Children With CML
The agency approved the tyrosine kinase inhibitor for pediatric patients with chronic phase Ph+ chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.
Stay updated with breaking news from Tbc Count. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency approved the tyrosine kinase inhibitor for pediatric patients with chronic phase Ph+ chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.
Over the last few years, physicians have experimented with taking patients with chronic myeloid leukemia (CML) off their drugs entirely, and the results are promising.
Protein changes in peripheral blood samples in the first 24 hours after starting chemotherapy could predict which patients with acute myeloid leukemia respond.
A new study suggests that Fitbit data — including heart rate and step count — could serve as a proxy for important clinical metrics, providing key insights to help treat chronic disease.
Children with more painful acute appendicitis appear to have less success with antibiotic treatment instead of surgery, researchers report.